117 related articles for article (PubMed ID: 37909947)
21. Mutations in DNA binding domain of p53 impede RSL1D1-p53 interaction to escape from degradation in human colorectal cancer cells.
Ding L; Zhao C; Xu Y; Zhang Z; Nie Y; Liao K; Chen Y; Tu B; Zhang X
Exp Cell Res; 2022 Aug; 417(1):113211. PubMed ID: 35597299
[TBL] [Abstract][Full Text] [Related]
22. The Mutant p53-Driven Secretome Has Oncogenic Functions in Pancreatic Ductal Adenocarcinoma Cells.
Butera G; Brandi J; Cavallini C; Scarpa A; Lawlor RT; Scupoli MT; Marengo E; Cecconi D; Manfredi M; Donadelli M
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32526853
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of the mitochondrial transport protein, Tim50, by mutant p53 contributes to cell growth and chemoresistance.
Sankala H; Vaughan C; Wang J; Deb S; Graves PR
Arch Biochem Biophys; 2011 Aug; 512(1):52-60. PubMed ID: 21621504
[TBL] [Abstract][Full Text] [Related]
24. Triptolide promotes degradation of the unfolded gain-of-function Tp53
Zhou J; Luo J; Li P; Zhou Y; Li P; Wang F; Mallio CA; Rossi G; Jalal AH; Filipovic N; Tian Z; Zhao X
Transl Lung Cancer Res; 2022 May; 11(5):802-816. PubMed ID: 35693277
[TBL] [Abstract][Full Text] [Related]
25. Intraperitoneal Administration of p53-armed Oncolytic Adenovirus Inhibits Peritoneal Metastasis of Diffuse-type Gastric Cancer Cells.
Hori N; Tazawa H; Li Y; Okura T; Kikuchi S; Kuroda S; Ohara T; Noma K; Nishizaki M; Urata Y; Kagawa S; Fujiwara T
Anticancer Res; 2023 Nov; 43(11):4809-4821. PubMed ID: 37909979
[TBL] [Abstract][Full Text] [Related]
26. MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer.
Yamasaki J; Hirata Y; Otsuki Y; Suina K; Saito Y; Masuda K; Okazaki S; Ishimoto T; Saya H; Nagano O
Cancer Sci; 2022 Mar; 113(3):916-925. PubMed ID: 34931404
[TBL] [Abstract][Full Text] [Related]
27. TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors.
Kim JY; Jung J; Kim KM; Lee J; Im YH
Cancer Med; 2023 Jun; 12(11):12438-12451. PubMed ID: 37081749
[TBL] [Abstract][Full Text] [Related]
28. Different TP53 mutations are associated with specific chromosomal rearrangements, telomere length changes, and remodeling of the nuclear architecture of telomeres.
Samassekou O; Bastien N; Lichtensztejn D; Yan J; Mai S; Drouin R
Genes Chromosomes Cancer; 2014 Nov; 53(11):934-50. PubMed ID: 25059482
[TBL] [Abstract][Full Text] [Related]
29. Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer.
Xiao G; Lundine D; Annor GK; Canar J; Ellison V; Polotskaia A; Donabedian PL; Reiner T; Khramtsova GF; Olopade OI; Mazo A; Bargonetti J
Cancer Res; 2020 Feb; 80(3):394-405. PubMed ID: 31776133
[TBL] [Abstract][Full Text] [Related]
30. Adhesion molecules and TGF-beta1 are involved in the peritoneal dissemination of NUGC-4 human gastric cancer cells.
Nakashio T; Narita T; Akiyama S; Kasai Y; Kondo K; Ito K; Takagi H; Kannagi R
Int J Cancer; 1997 Mar; 70(5):612-8. PubMed ID: 9052764
[TBL] [Abstract][Full Text] [Related]
31. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
32. Mutant p53 cooperates with knockdown of endogenous wild-type p53 to disrupt tubulogenesis in Madin-Darby canine kidney cells.
Zhang Y; Yan W; Chen X
PLoS One; 2013; 8(12):e85624. PubMed ID: 24386484
[TBL] [Abstract][Full Text] [Related]
33. Molecular dynamics study on the inhibition mechanisms of ReACp53 peptide for p53-R175H mutant aggregation.
Lei J; Cai M; Shen Y; Lin D; Deng X
Phys Chem Chem Phys; 2021 Oct; 23(40):23032-23041. PubMed ID: 34612239
[TBL] [Abstract][Full Text] [Related]
34. A CD24-p53 axis contributes to African American prostate cancer disparities.
Liu W; Zhang Y; Wei S; Bae S; Yang WH; Smith GJ; Mohler JL; Fontham ETH; Bensen JT; Sonpavde GP; Chen GY; Liu R; Wang L
Prostate; 2020 May; 80(8):609-618. PubMed ID: 32168400
[TBL] [Abstract][Full Text] [Related]
35. Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis.
Ju Q; Zhao L; Gao J; Zhou L; Xu Y; Sun Y; Zhao X
Chin J Cancer Res; 2019 Jun; 31(3):533-546. PubMed ID: 31354222
[TBL] [Abstract][Full Text] [Related]
36. Mutants TP53 p.R273H and p.R273C but not p.R273G enhance cancer cell malignancy.
Li J; Yang L; Gaur S; Zhang K; Wu X; Yuan YC; Li H; Hu S; Weng Y; Yen Y
Hum Mutat; 2014 May; 35(5):575-84. PubMed ID: 24677579
[TBL] [Abstract][Full Text] [Related]
37. A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells.
Garufi A; Trisciuoglio D; Porru M; Leonetti C; Stoppacciaro A; D'Orazi V; Avantaggiati M; Crispini A; Pucci D; D'Orazi G
J Exp Clin Cancer Res; 2013 Oct; 32(1):72. PubMed ID: 24220325
[TBL] [Abstract][Full Text] [Related]
38. A common gain of function of p53 cancer mutants in inducing genetic instability.
Liu DP; Song H; Xu Y
Oncogene; 2010 Feb; 29(7):949-56. PubMed ID: 19881536
[TBL] [Abstract][Full Text] [Related]
39. Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species.
Kalo E; Kogan-Sakin I; Solomon H; Bar-Nathan E; Shay M; Shetzer Y; Dekel E; Goldfinger N; Buganim Y; Stambolsky P; Goldstein I; Madar S; Rotter V
J Cell Sci; 2012 Nov; 125(Pt 22):5578-86. PubMed ID: 22899716
[TBL] [Abstract][Full Text] [Related]
40. Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis.
Tang J; Feng Y; Kuick R; Green M; Green M; Sakamoto N; Kurosu Y; Lin J; Cho KR; Fearon ER
Lab Invest; 2019 Oct; 99(10):1454-1469. PubMed ID: 31148594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]